Decisions may depend on thymoma and what type of auto-antibodies are present ...

Five-year results from the extended randomized MGTX trial demonstrated that the addition of thymectomy to prednisone leads to long-lasting lower quantitative myasthenia gravis (QMG) scores and ...

The tool can help clinicians stratify patients into high-risk and low-risk categories. A team of investigators has developed a nomogram they say can help predict which patients with myasthenia gravis ...

Please provide your email address to receive an email when new articles are posted on . demonstrated superiority of thymectomy and prednisone compared to prednisone alone at 3 and 5 years post-surgery ...

BOSTON -- Thymectomy combined with prednisone therapy in patients with nonthymomatous (no thymus tumor) myasthenia gravis (MG) resulted in better three-year patient outcomes than steroid therapy alone ...

Please provide your email address to receive an email when new articles are posted on . Patients with myasthenia gravis — particularly those post-thymectomy — demonstrate an increased odds for having ...

.BUFFALO, N.Y. — The first-ever randomized study of the removal of the thymus gland in treating myasthenia gravis was conducted in 2016. Led by Gil I. Wolfe, MD, SUNY Distinguished Professor and the ...

For several decades, thymectomy has been an option for the treatment of myasthenia gravis, a rare, long-term, autoimmune neuromuscular disease. This randomized clinical trial, carried out in 67 ...

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Nicholas Silvestri ...

The first-ever randomized study of the removal of the thymus gland in treating myasthenia gravis was conducted in 2016. Led by Gil I. Wolfe, MD, SUNY Distinguished Professor and the Irvin and Rosemary ...